Health-related quality of life in acute myeloid leukemia patients not eligible for intensive chemotherapy: results of a systematic literature review
Anna Forsythe,1 Christina S Kwon,1 Timothy Bell,2 T Alexander Smith,3 Bhakti Arondekar4 1Purple Squirrel Economics, New York, NY, USA; 2Pfizer Inc, New York, NY, USA; 3Pfizer Ltd, Walton Oaks, UK; 4Pfizer Inc, Collegeville, PA, USA Background: AML is a rapidly progressing bone marrow cancer, with po...
Saved in:
Main Authors: | Forsythe A (Author), Kwon CS (Author), Bell T (Author), Smith TA (Author), Arondekar B (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Targeting and Rational Chemotherapy in Acute Myeloid Leukemia
by: Pourrajab F, et al.
Published: (2020) -
Papular eruption after induction chemotherapy for acute myeloid leukemia
by: Taylor Novice, BS, et al.
Published: (2020) -
Infectious complications during induction chemotherapy in children with acute myeloid leukemia
by: K.G. Gopakumar, et al.
Published: (2016) -
Systematic review of health state utility values for acute myeloid leukemia
by: Forsythe A, et al.
Published: (2018) -
Conservative Management of Presumed Fetal Anemia Secondary to Maternal Chemotherapy for Acute Myeloid Leukemia
by: Christina M. Nowik, et al.
Published: (2021)